Drug Type Small molecule drug |
Synonyms Eberconazol, Eberconazole, WAS 2160 + [2] |
Target |
Mechanism fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date ES (01 Jan 2005), |
Regulation- |
Molecular FormulaC18H15Cl2N3O3 |
InChIKeyDPHMSVRBAXJSPF-UHFFFAOYSA-N |
CAS Registry130104-32-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07884 | Eberconazole Nitrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Mycoses | ES | 01 Jan 2005 | |
Tinea | ES | 01 Jan 2005 | |
Tinea Pedis | ES | 01 Jan 2005 |
NCT01993823 (Pubmed) Manual | Phase 3 | 190 | ybunejuhuf(nydwzgaeny) = xbfkczhbwx tivyyqvvpt (lpuvuorzon ) | Positive | 01 May 2018 | ||
ybunejuhuf(nydwzgaeny) = tidzbbceot tivyyqvvpt (lpuvuorzon ) |